SCHEMBL1010889

SCHEMBL1010889

CC(C)C1=CC2CCC1C2

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27586420 0.78 CYP19A1 (0.36) CYP19A1
SCHEMBL28322139 0.73
SCHEMBL28210087 0.72
SCHEMBL4778430 0.70
SCHEMBL2315400 0.69
SCHEMBL6557525 0.69 HIF1A (0.36)
SCHEMBL1012760 0.68 CYP19A1 (0.32) CYP19A1
SCHEMBL10430463 0.68 CYP19A1 (0.35) CYP19A1
SCHEMBL11188049 0.68 SPHK1 (0.31)
SCHEMBL17491859 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112745431-B Cycloolefin copolymer and preparation method thereof 广东华锦达新材科技有限公司 2023-04-21 CN claimed
CN-112745431-A Cycloolefin copolymer and preparation method thereof 广东新华粤石化集团股份公司 2021-05-04 CN claimed
EP-1372844-B1 HIGH ACTIVITY METAL CARBENE METATHESIS CATALYSTS GENERATED USING A THERMALLY ACTIVATED N-HETEROCYCLIC CARBENE PRECURSOR CALIFORNIA INST OF TECHN (US) 2011-01-05 EP claimed
US-6838489-B2 High activity metal carbene metathesis catalysts generated using a thermally activated N-heterocyclic carbene precursor CYMETECH, LLC (US) 2005-01-04 US claimed
US-20030144437-A1 High activity metal carbene metathesis catalysts generated using a thermally activated N-heterocyclic carbene precursor STERLING JA, L.C. 2003-07-31 US claimed
US-5126065-A PROCESS FOR IMPROVING THE COEFFICIENT OF TRACTION AND TRACTION DRIVE FLUID IDEMITSU KOSAN CO., LTD. (JP) 1992-06-30 US claimed
EP-0002278-B1 RING-OPENED DIMETHYLNORBORNENE AND ISOPROPYLNORBORNENE COPOLYMERS The B.F. GOODRICH Company (US) 1983-09-07 EP claimed
EP-0002278-A1 Ring-opened dimethylnorbornene and isopropylnorbornene copolymers The B.F. GOODRICH Company (US) 1979-06-13 EP claimed
US-4136247-A POLYALKENAMERS, IMPACT STRENGTH, HEAT RESISTANCE THE B. F. GOODRICH COMPANY (US) 1979-01-23 US claimed
EP-4267548-A1 COMPOSITIONS AND METHODS RELATED TO BICYCLO[2.2.1] HEPTANAMINE-CONTAINING COMPOUNDS The Broad Institute Inc. (US) 2023-11-01 EP disclosed
CN-112745431-B Cycloolefin copolymer and preparation method thereof 广东华锦达新材科技有限公司 2023-04-21 CN disclosed
WO-2022140654-A1 COMPOSITIONS AND METHODS RELATED TO BICYCLO[2.2.1] HEPTANAMINE-CONTAINING COMPOUNDS THE BROAD INSTITUTE, INC. (US) 2022-06-30 WO disclosed
CN-112745431-A Cycloolefin copolymer and preparation method thereof 广东新华粤石化集团股份公司 2021-05-04 CN disclosed
CN-109071913-B Aqueous dispersion, coating film, and laminate 住友化学株式会社 2021-03-30 CN disclosed
US-4372863-A Oil compositions containing oil-soluble, oxidatively and mechanically degraded ethylene copolymers EXXON RESEARCH & ENGINEERING CO. (US) 1983-02-08 US disclosed
EP-0002278-A1 Ring-opened dimethylnorbornene and isopropylnorbornene copolymers The B.F. GOODRICH Company (US) 1979-06-13 EP disclosed
EP-0002278-A1 Ring-opened dimethylnorbornene and isopropylnorbornene copolymers The B.F. GOODRICH Company (US) 1979-06-13 EP disclosed
EP-0002278-A1 Ring-opened dimethylnorbornene and isopropylnorbornene copolymers The B.F. GOODRICH Company (US) 1979-06-13 EP disclosed
US-4136247-A POLYALKENAMERS, IMPACT STRENGTH, HEAT RESISTANCE THE B. F. GOODRICH COMPANY (US) 1979-01-23 US disclosed
US-4136247-A POLYALKENAMERS, IMPACT STRENGTH, HEAT RESISTANCE THE B. F. GOODRICH COMPANY (US) 1979-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144437-A1 High activity metal carbene metathesis catalysts generated using a thermally activated N-heterocyclic carbene precursor NQO1, NIT2, ALOX5 CYP19A1 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.